Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $32.0400 (-17.53%) ($31.3100 - $36.2100) on Mon. Mar. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.27% (three month average) | RSI | 73 | Latest Price | $32.0400(-17.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -2.2% a day on average for past five trading days. | Weekly Trend | IOVA advances 18.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(51%) XBI(50%) ARKG(49%) IWO(46%) ARKK(44%) | Factors Impacting IOVA price | IOVA will decline at least -2.635% in a week (0% probabilities). VIXM(-30%) VXX(-16%) UUP(-10%) TLT(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.635% (StdDev 5.27%) | Hourly BBV | 0 () | Intraday Trend | -11% | | | |
|
5 Day Moving Average | $35.89(-10.73%) | 10 Day Moving Average | $34.72(-7.72%) | 20 Day Moving Average | $29.76(7.66%) | To recent high | -17.5% | To recent low | 48.1% | Market Cap | $4.692b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |